Literature DB >> 9194032

Prognostic value of histology in patients with non-small cell lung cancer.

A Charloux1, G Hedelin, A Dietemann, T Ifoundza, N Roeslin, G Pauli, E Quoix.   

Abstract

To evaluate the impact of non-small cell lung cancer (NSCLC) histological subtypes on survival, we performed a retrospective multivariate analysis of survival in 361 patients with a NSCLC diagnosed in 1987 and 1988 at the University Hospital in Strasbourg, France. There were 262 (73%) squamous cell carcinomas (SQ), 59 (16%) adenocarcinomas other than bronchioloalveolar carcinoma (ADOBAC), 24 (7%) bronchioloalveolar carcinoma (BAC) and 16 (4%) large cell carcinomas (LC). The proportion of metastatic disease was significantly higher in the ADOBAC group than in the SQ group (30% vs. 15%, P < 0.001). In operated patients, only extent of disease and age were independent prognostic factors. In patients with unresectable NSCLC, extent of disease had also the heaviest impact on survival. However, in these unresected patients, ADOBAC had a pejorative impact on survival, in contrast to BAC which was of better prognosis. If these results are confirmed by prospective studies, this will support stratification according to histological subtypes in clinical trials involving inoperable NSCLC patients.

Entities:  

Mesh:

Year:  1997        PMID: 9194032     DOI: 10.1016/s0169-5002(97)00655-7

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

1.  Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer.

Authors:  Rhizlane Belbaraka; Olivier Trédan; Isabelle Ray-Coquard; Giselle Chvetzoff; Agathe Bajard; David Pérol; Nabil Ismaili; Mohammed Ismaili; Hassan Errihani; Thomas Bachelot; Paul Rebattu
Journal:  BMC Res Notes       Date:  2010-06-10

2.  A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index.

Authors:  B Colinet; W Jacot; D Bertrand; S Lacombe; M-C Bozonnat; J-P Daurès; J-L Pujol
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

3.  Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors.

Authors:  W Jacot; X Quantin; J M Boher; F Andre; L Moreau; M Gainet; A Depierre; E Quoix; T L Chevalier; J L Pujol
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

4.  Non-small-cell lung cancer in a French department, (1982-1997): management and outcome.

Authors:  J Foeglé; G Hédelin; M P Lebitasy; A Purohit; M Velten; E Quoix
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

5.  Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer.

Authors:  Pierre-Jean Lamy; Carine Plassot; Jean-Louis Pujol
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

6.  Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer.

Authors:  Masayuki Aboshi; Masayuki Kaneko; Mamoru Narukawa
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-22       Impact factor: 4.553

7.  Predicting recurrence using the clinical factors of patients with non-small cell lung cancer after curative resection.

Authors:  Hyun Joo Lee; Jisuk Jo; Dae-Soon Son; Jinseon Lee; Yong Soo Choi; Kwhanmien Kim; Young Mog Shim; Jhingook Kim
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

8.  [Primary lung adenocarcinoma: experience of a Tunisian hospital].

Authors:  Samah Joobeur; Hadhami Mribah; Ahmed Ben Saad; Saoussen Cheikh Mhamed; Houda Mahou; Naceur Rouatbi; Ali El Kamel
Journal:  Pan Afr Med J       Date:  2015-07-24

9.  The XRCC1 Arg194Trp polymorphism is significantly associated with lung adenocarcinoma: a case-control study in an Eastern European Caucasian group.

Authors:  Andreea Cătană; Monica Pop; Bianca Domokos Hincu; Ioan V Pop; Felicia M Petrişor; Mihai D Porojan; Radu A Popp
Journal:  Onco Targets Ther       Date:  2015-11-27       Impact factor: 4.147

10.  The Expression Levels of IL-4/IL-13/STAT6 Signaling Pathway Genes and SOCS3 Could Help to Differentiate the Histopathological Subtypes of Non-Small Cell Lung Carcinoma.

Authors:  Dorota Pastuszak-Lewandoska; Daria Domańska-Senderowska; Adam Antczak; Jacek Kordiak; Paweł Górski; Karolina H Czarnecka; Monika Migdalska-Sęk; Ewa Nawrot; Justyna M Kiszałkiewicz; Ewa Brzeziańska-Lasota
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.